These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7645950)
1. Antiproliferative effects of four different cytokines on renal carcinoma cell lines. Buszello H Anticancer Res; 1995; 15(3):735-8. PubMed ID: 7645950 [TBL] [Abstract][Full Text] [Related]
2. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line. Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105 [TBL] [Abstract][Full Text] [Related]
3. Prevention of resistance to IFN-alpha antiproliferative activity: characterization of the effect of IFN-gamma and substitution for IFN-gamma by tumor necrosis factor. Fleischmann CM; Stanton GJ; Fleischmann WR J Biol Regul Homeost Agents; 1993; 7(2):50-7. PubMed ID: 8266815 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. Morikawa K; Fidler IJ J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665 [TBL] [Abstract][Full Text] [Related]
5. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent]. Ohmura K; Tsukamoto T Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371 [TBL] [Abstract][Full Text] [Related]
6. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer. Wang Z; Cheng Y; Zheng R; Qin D; Liu G Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335 [TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid. Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439 [TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors. Kost ER; Mutch DG; Herzog TJ Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112 [TBL] [Abstract][Full Text] [Related]
9. Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C. Okamoto E; Kinne RK; Sökeland J J Urol; 1996 Oct; 156(4):1492-5. PubMed ID: 8808915 [TBL] [Abstract][Full Text] [Related]
10. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines. Matsuo S; Takano S; Yamashita J; Ogawa M Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224 [TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of breast cancer cell lines by combinations of anti-P185HER2 monoclonal antibody and cytokines. Kopreski MS; Lipton A; Harvey HA; Kumar R Anticancer Res; 1996; 16(1):433-6. PubMed ID: 8615649 [TBL] [Abstract][Full Text] [Related]
12. IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon. Bode H; Schmitz H; Fromm M; Scholz P; Riecken EO; Schulzke JD Cytokine; 1998 Jun; 10(6):457-65. PubMed ID: 9632533 [TBL] [Abstract][Full Text] [Related]
14. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells. Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 production by T cells: a study of the immunoregulatory actions of interferon-alpha, interferon-gamma, and tumor necrosis factor-alpha in phenotypically different T cell clones. Dao T; Holán V; Minowada J Cell Immunol; 1993 Oct; 151(2):451-9. PubMed ID: 8402948 [TBL] [Abstract][Full Text] [Related]
16. Regulation of ovarian UT-OC-2 carcinoma cells by cytokines: effects on cell proliferation, activation of transcription factors and apoptosis. Seppänen M; Lin L; Saarinen R; Punnonen R; Vihko KK Acta Obstet Gynecol Scand; 2008; 87(9):902-9. PubMed ID: 18720042 [TBL] [Abstract][Full Text] [Related]
17. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Zeimet AG; Marth C; Offner FA; Obrist P; Uhl-Steidl M; Feichtinger H; Stadlmann S; Daxenbichler G; Dapunt O Gynecol Oncol; 1996 Sep; 62(3):384-9. PubMed ID: 8812537 [TBL] [Abstract][Full Text] [Related]
18. [Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line]. Gohji K; Hamami G; Kamidono S Hinyokika Kiyo; 1987 Mar; 33(3):329-35. PubMed ID: 3113191 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of cytokines on ovarian and endometrial carcinoma cells in vitro with special reference to induction of specific transcriptional regulators. Seppänen M; Henttinen T; Lin L; Punnonen J; Grénman S; Punnonen R; Vihko KK Oncol Res; 1998; 10(11-12):575-89. PubMed ID: 10367939 [TBL] [Abstract][Full Text] [Related]
20. Is interferon gamma one key of metastatic potential increase in human bladder carcinoma? Champelovier P; Simon A; Garrel C; Levacher G; Praloran V; Seigneurin D Clin Cancer Res; 2003 Oct; 9(12):4562-9. PubMed ID: 14555531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]